14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026
VEEV vs DOCS: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 17, 2026, Veeva Systems Inc. (VEEV) is the stronger overall head-to-head candidate over Doximity, Inc. (DOCS) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). VEEV carries a Unified Composite Score of 48.5/100 (HOLD) at $290.25 (34.8x Forward P/E, 29.9% operating margin), whereas DOCS carries 56.2/100 (HOLD) at $31.25 (20.2x Forward P/E, 27.1% operating margin).
Composite vs. Pillar Nuance: While DOCS currently prints a higher short-term Unified Composite Score (56.2/100 HOLD vs. VEEV 48.5/100 HOLD), VEEV captures the overall institutional head-to-head verdict (7–3 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (29.9% vs. 27.1% operating margin) and revenue trajectory (+17.6% vs. +3.6% YoY).
Competes within the Health Information Services value chain with $5.9B market capitalization and 27.1% operating margin.
OpEx & R&D Reinvestment59.7% of Rev ($395M)
90D Engineering Disclosures0 Published
Investor FAQ VEEV vs DOCS Key Questions & Quantitative Answers
As of Nov 17, 2026, Veeva Systems Inc. (VEEV) is the stronger overall head-to-head candidate over Doximity, Inc. (DOCS) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). VEEV carries a Unified Composite Score of 48.5/100 (HOLD) at $290.25 (34.8x Forward P/E, 29.9% operating margin), whereas DOCS carries 56.2/100 (HOLD) at $31.25 (20.2x Forward P/E, 27.1% operating margin). Composite vs. Pillar Nuance: While DOCS currently prints a higher short-term Unified Composite Score (56.2/100 HOLD vs. VEEV 48.5/100 HOLD), VEEV captures the overall institutional head-to-head verdict (7–3 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (29.9% vs. 27.1% operating margin) and revenue trajectory (+17.6% vs. +3.6% YoY).
VEEV leads the Growth & Scale pillar: VEEV posts +17.6% YoY revenue growth and +39.5% YoY earnings growth on $3.46B TTM revenue (75.0% gross margin, 29.9% operating margin), compared with DOCS at +3.6% YoY revenue growth and -41.9% YoY earnings growth on $662M TTM revenue (86.8% gross margin, 27.1% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), VEEV cumulative revenue shifted +272.1% while DOCS shifted +433.3%. In operating R&D and SG&A reinvestment, VEEV deploys 45.1% of Rev ($1.56B) (0 90-day corporate R&D disclosures) versus 59.7% of Rev ($395M) (0 disclosures) for DOCS.
DOCS screens cheaper on headline valuation multiples. VEEV trades at 34.8x Forward P/E, 49.4x Trailing P/E, 1.16x PEG, and 13.6x EV/Revenue (48.2% FCF margin), whereas DOCS trades at 20.2x Forward P/E, 46.3x Trailing P/E, 0.59x PEG, and 8.7x EV/Revenue (44.9% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against VEEV (14.4% ROE) versus DOCS (13.8% ROE) capital efficiency.
In options market volatility and institutional positioning, VEEV carries 45.0% implied volatility (55th %ile, Balanced (25th–60th %ile)), a 0.71x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.39β · 20% Vol realized risk). By comparison, DOCS carries 42.5% implied volatility (33rd %ile, Balanced (25th–60th %ile)), a 0.25x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a SURGE options structure phase (0.68β · 42% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.